Consun Pharmaceutical Group (HKSE:01681) Other Current Liabilities : HK$499 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Other Current Liabilities?

Consun Pharmaceutical Group's other current liabilities for the quarter that ended in Dec. 2023 was HK$499 Mil.

Consun Pharmaceutical Group's quarterly other current liabilities increased from Dec. 2022 (HK$469 Mil) to Jun. 2023 (HK$548 Mil) but then declined from Jun. 2023 (HK$548 Mil) to Dec. 2023 (HK$499 Mil).

Consun Pharmaceutical Group's annual other current liabilities increased from Dec. 2021 (HK$403 Mil) to Dec. 2022 (HK$469 Mil) and increased from Dec. 2022 (HK$469 Mil) to Dec. 2023 (HK$499 Mil).

Consun Pharmaceutical Group Other Current Liabilities Historical Data

The historical data trend for Consun Pharmaceutical Group's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Other Current Liabilities Chart

Consun Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Consun Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Consun Pharmaceutical Group Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Consun Pharmaceutical Group Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group (HKSE:01681) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Other Current Liabilities

Traded in Other Exchanges

C1P:Germany

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines